UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

100O Results of A Randomized Phase 2 Study of Pd 0332991, A Cyclin-Dependent Kinase (Cdk) 4/6 Inhibitor, In Combination with Letrozole vs Letrozole Alone For First-Line Treatment of ER + /Her2- Advanced Breast Cancer (Bc)

Annals of oncology, 2012-05, Vol.23, p.ii43

2012

Volltextzugriff (PDF)

Thermal diffusivity and conductivity of moist porous media

Soil Science Society of America journal, 1979-09, Vol.43 (5), p.1050-1052

1979

Volltextzugriff (PDF)

Nonrestorative Treatments for Caries: Systematic Review and Network Meta-analysis

Journal of Dental Research, 2019-01, Vol.98 (1), p.14-26

2019

Volltextzugriff (PDF)

Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy

The New England journal of medicine, 2017-07, Vol.377 (4), p.338-351

2017

Volltextzugriff (PDF)

1605P Opevesostat (MK-5684/ODM-208), an oral CYP11A1 inhibitor, in metastatic castration-resistant prostate cancer (mCRPC): Updated CYPIDES phase II results

Annals of oncology, 2024-09, Vol.35, p.S968-S968

2024

Volltextzugriff (PDF)

Oxaliplatin Increases Disease-Free Survival in Rectal Cancer: A Single-Institution Experience

International journal of radiation oncology, biology, physics, 2016-10, Vol.96 (2), p.E168-E169

2016

Volltextzugriff (PDF)

Short-Term Endpoints for Neoadjuvant Rectal Cancer Therapy: Pathologic Complete Response or Neoadjuvant Rectal Cancer Score?

International journal of radiation oncology, biology, physics, 2016-10, Vol.96 (2), p.E201-E201

2016

Volltextzugriff (PDF)

Prostate Advanced Radiation Technologies Investigating Quality of Life (PARTIQoL): A Phase III Randomized Clinical Trial of Proton Therapy vs. IMRT for Low or Intermediate Risk Prostate Cancer

International journal of radiation oncology, biology, physics, 2023-10, Vol.117 (2), p.e450-e450

2023

Volltextzugriff (PDF)

Early Prediction of Trauma Patient Discharge Disposition

The Journal of surgical research, 2014-02, Vol.186 (2), p.676-676

2014

Volltextzugriff (PDF)

Habitat Escalated Adaptive Therapy (HEAT): A Phase 2 Trial Utilizing Radiomic Habitat-Directed and Genomic-Adjusted Radiation Dose (GARD) Optimization for High-Grade Soft Tissue Sarcoma

International journal of radiation oncology, biology, physics, 2024-10, Vol.120 (2), p.S88-S89

2024

Volltextzugriff (PDF)

Comprehensive genomic and immune profiling of non-V600 BRAF-mutated melanomas: Implications for therapeutic strategies beyond BRAF/MEK inhibitors

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.e21544-e21544

2024

Volltextzugriff (PDF)

LBA4 Adjuvant nivolumab plus ipilimumab (NIVO+IPI) vs placebo (PBO) for localized renal cell carcinoma (RCC) at high risk of relapse after nephrectomy: Results from the randomized, phase III CheckMate 914 trial

Annals of oncology, 2022-09, Vol.33, p.S1430

2022

Volltextzugriff (PDF)

Restructuring of RVUs assigned to retrieval of IVC filters reinforces a clinical practice model

Journal of vascular and interventional radiology, 2014-03, Vol.25 (3), p.S10-S11

2014

Volltextzugriff (PDF)

JAK inhibitor treatment for inborn errors of JAK/STAT signaling: An ESID/EBMT-IEWP retrospective study

Journal of allergy and clinical immunology, 2024-01, Vol.153 (1), p.275-286.e18

2024

Volltextzugriff (PDF)

Sequential Short Course Radiation and FOLFOX as Preoperative Therapy for Rectal Cancer: Favorable LC, PFS, and QOL at 2 Years

International journal of radiation oncology, biology, physics, 2013-10, Vol.87 (2), p.S88-S88

2013

Volltextzugriff (PDF)

Matched Pair Analysis of Sequential Short Course Radiation Therapy and FOLFOX Chemotherapy as Preoperative Therapy for Rectal Cancer: Improved DFS Compared to Institutional Controls Favors Near-Total Neoadjuvant Therapy

International journal of radiation oncology, biology, physics, 2015-11, Vol.93 (3), p.S125-S125

2015

Volltextzugriff (PDF)

THU0675 The impact of autoimmune rheumatic diseases on birth outcomes in an ethnically diverse cohort of women in the united states

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.531

2018

Volltextzugriff (PDF)

Phase I/II study of combined BCL-XL and MEK inhibition with navitoclax (N) and trametinib (T) in KRAS or NRAS mutant advanced solid tumours

Annals of oncology, 2019-10, Vol.30, p.v164

2019

Volltextzugriff (PDF)

447PD - Phase I/II study of combined BCL-XL and MEK inhibition with navitoclax (N) and trametinib (T) in KRAS or NRAS mutant advanced solid tumours

Annals of oncology, 2019-10, Vol.30, p.v164-v164

2019

Volltextzugriff (PDF)

Neoadjuvant Rectal Cancer (NAR) Score Applied to Phase 2 Trial of Short Course Radiation (RT) and FOLFOX as Preoperative Therapy for Rectal Cancer Supports a Total Neoadjuvant Approach

International journal of radiation oncology, biology, physics, 2014-09, Vol.90 (1), p.S389-S389

2014

Volltextzugriff (PDF)

Corrigendum to Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial: Ann Oncol 2019; 30: 1992–2003

Annals of oncology, 2020-03, Vol.31 (3), p.442-442

2020

Volltextzugriff (PDF)

NRG Oncology/RTOG 0529: Long-Term Outcomes of Dose-Painted Intensity Modulated Radiation Therapy, 5-Fluorouracil, and Mitomycin-C in Anal Canal Cancer

International journal of radiation oncology, biology, physics, 2017-10, Vol.99 (2), p.S64-S65

2017

Volltextzugriff (PDF)

Preliminary Demonstration of a Dose Response with Concurrent Gemcitabine and Radiation in Locally Advanced Pancreatic Adenocarcinoma

International journal of radiation oncology, biology, physics, 2011, Vol.81 (2), p.S340-S341

2011

Volltextzugriff (PDF)

1:30 PM; Abstract No. 8 - Restructuring of RVUs assigned to retrieval of IVC filters reinforces a clinical practice model

Journal of vascular and interventional radiology, 2014-03, Vol.25 (3), p.S10-S11

2014

Volltextzugriff (PDF)

19LBA Docetaxel (Doc) +/− zoledronic acid (ZA) for hormone-naive prostate cancer: First overall survival results from STAMPEDE & treatment effects within subgroups (NCT00268476)

European journal of cancer (1990), 2015-09, Vol.51, p.S719-S719

2015

Volltextzugriff (PDF)

1 – 25 von 50

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(39)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(50)

Sprache

Englisch
(50)

Erscheinungsjahr

n.n

Thema

Science & Technology
(12)
Hematology, Oncology And Palliative Medicine
(10)
Radiology
(10)
Life Sciences & Biomedicine
(7)
Humans
(5)
Male
(4)
Biological And Medical Sciences
(3)
Medical Sciences
(3)
Physical Sciences
(3)
Physics
(3)
Technology
(3)
Adult
(2)
Animals
(2)
Clinical Trials
(2)
Crystallography
(2)
Disease Models, Animal
(2)
Engineering
(2)
Exact Sciences And Technology
(2)
Materials Science
(2)
Mice
(2)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

100O Results of A Randomized Phase 2 Study of Pd 0332991, A Cyclin-Dependent Kinase (Cdk) 4/6 Inhibitor, In Combination with Letrozole vs Letrozole Alone For First-Line Treatment of ER + /Her2- Advanced Breast Cancer (Bc)

Thermal diffusivity and conductivity of moist porous media

Nonrestorative Treatments for Caries: Systematic Review and Network Meta-analysis

Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy

1605P Opevesostat (MK-5684/ODM-208), an oral CYP11A1 inhibitor, in metastatic castration-resistant prostate cancer (mCRPC): Updated CYPIDES phase II results

Oxaliplatin Increases Disease-Free Survival in Rectal Cancer: A Single-Institution Experience

Short-Term Endpoints for Neoadjuvant Rectal Cancer Therapy: Pathologic Complete Response or Neoadjuvant Rectal Cancer Score?

Prostate Advanced Radiation Technologies Investigating Quality of Life (PARTIQoL): A Phase III Randomized Clinical Trial of Proton Therapy vs. IMRT for Low or Intermediate Risk Prostate Cancer

Early Prediction of Trauma Patient Discharge Disposition

Habitat Escalated Adaptive Therapy (HEAT): A Phase 2 Trial Utilizing Radiomic Habitat-Directed and Genomic-Adjusted Radiation Dose (GARD) Optimization for High-Grade Soft Tissue Sarcoma

Comprehensive genomic and immune profiling of non-V600 BRAF-mutated melanomas: Implications for therapeutic strategies beyond BRAF/MEK inhibitors

LBA4 Adjuvant nivolumab plus ipilimumab (NIVO+IPI) vs placebo (PBO) for localized renal cell carcinoma (RCC) at high risk of relapse after nephrectomy: Results from the randomized, phase III CheckMate 914 trial

Restructuring of RVUs assigned to retrieval of IVC filters reinforces a clinical practice model

JAK inhibitor treatment for inborn errors of JAK/STAT signaling: An ESID/EBMT-IEWP retrospective study

Sequential Short Course Radiation and FOLFOX as Preoperative Therapy for Rectal Cancer: Favorable LC, PFS, and QOL at 2 Years

Matched Pair Analysis of Sequential Short Course Radiation Therapy and FOLFOX Chemotherapy as Preoperative Therapy for Rectal Cancer: Improved DFS Compared to Institutional Controls Favors Near-Total Neoadjuvant Therapy

THU0675 The impact of autoimmune rheumatic diseases on birth outcomes in an ethnically diverse cohort of women in the united states

Phase I/II study of combined BCL-XL and MEK inhibition with navitoclax (N) and trametinib (T) in KRAS or NRAS mutant advanced solid tumours

447PD - Phase I/II study of combined BCL-XL and MEK inhibition with navitoclax (N) and trametinib (T) in KRAS or NRAS mutant advanced solid tumours

Neoadjuvant Rectal Cancer (NAR) Score Applied to Phase 2 Trial of Short Course Radiation (RT) and FOLFOX as Preoperative Therapy for Rectal Cancer Supports a Total Neoadjuvant Approach

Corrigendum to Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial: Ann Oncol 2019; 30: 1992–2003

NRG Oncology/RTOG 0529: Long-Term Outcomes of Dose-Painted Intensity Modulated Radiation Therapy, 5-Fluorouracil, and Mitomycin-C in Anal Canal Cancer

Preliminary Demonstration of a Dose Response with Concurrent Gemcitabine and Radiation in Locally Advanced Pancreatic Adenocarcinoma

1:30 PM; Abstract No. 8 - Restructuring of RVUs assigned to retrieval of IVC filters reinforces a clinical practice model

19LBA Docetaxel (Doc) +/− zoledronic acid (ZA) for hormone-naive prostate cancer: First overall survival results from STAMPEDE & treatment effects within subgroups (NCT00268476)

Suchergebnisse filtern